Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Common Stock | Options Exercise | +7.44K | +2.04% | 373K | Oct 15, 2023 | Direct | F1 | ||
transaction | GBIO | Common Stock | Tax liability | -$7.07K | -2.18K | -0.59% | $3.24 | 370K | Oct 15, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -7.44K | -50% | $0.00 | 7.44K | Oct 15, 2023 | Common Stock | 7.44K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
F2 | On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. |